In the UK, rates of obesity have increased by 30% in women, 40% in men, and 50% in children within the last decade resulting in over 25% of adults classified as obese today.
Obesity, in particular central obesity, is the dominant risk factor for insulin resistance, metabolic syndrome and type II diabetes. Evidence supporting obesity as an inflammation condition continues to grow and this is directly linked to the development of insulin resistance.
This webinar discusses novel approaches for the treatment and prevention of the common morbidities associated with obesity, specifically insulin resistance and type II diabetes, through targeting obesity-induced inflammatory processes.
Adipose tissue as an endocrine organ:
Adipose tissue has been recognized as the quantitatively most important energy store of the human body for many years, in addition to its functions as mechanical and thermal insulator. During the last 10 years, adipose tissue has come into focus as an endocrine organ important for development of many diseases related to obesity including insulin resistance, type 2 diabetes, dyslipidemia, hypertension and cardiovascular disease. Adipose tissue secretes a variety of bioactive peptides that play important roles in insulin action, energy homeostasis, inflammation, and cell growth. These secretory proteins from the adipose organ are named adipokines and have many physiological effects on different organs including the brain, bone, reproductive organs, liver, skeletal muscles, immune cells and blood vessels. Adipokines may locally regulate fat mass by modulating adipocyte size/number or angiogenesis and inversely increased fat mass leads to dysregulation of adipocyte functions.
In the UK, rates of obesity have increased by 30% in women, 40% in men, and 50% in children within the last decade resulting in over 25% of adults classified as obese today.
Obesity, in particular central obesity, is the dominant risk factor for insulin resistance, metabolic syndrome and type II diabetes. Evidence supporting obesity as an inflammation condition continues to grow and this is directly linked to the development of insulin resistance.
This webinar discusses novel approaches for the treatment and prevention of the common morbidities associated with obesity, specifically insulin resistance and type II diabetes, through targeting obesity-induced inflammatory processes.
Adipose tissue as an endocrine organ:
Adipose tissue has been recognized as the quantitatively most important energy store of the human body for many years, in addition to its functions as mechanical and thermal insulator. During the last 10 years, adipose tissue has come into focus as an endocrine organ important for development of many diseases related to obesity including insulin resistance, type 2 diabetes, dyslipidemia, hypertension and cardiovascular disease. Adipose tissue secretes a variety of bioactive peptides that play important roles in insulin action, energy homeostasis, inflammation, and cell growth. These secretory proteins from the adipose organ are named adipokines and have many physiological effects on different organs including the brain, bone, reproductive organs, liver, skeletal muscles, immune cells and blood vessels. Adipokines may locally regulate fat mass by modulating adipocyte size/number or angiogenesis and inversely increased fat mass leads to dysregulation of adipocyte functions.
The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...Randox Reagents
Obesity is a major risk factor for type 2 diabetes mellitus (T2DM), insulin resistance (IR), cardiovascular disease (CVD) and various types of malignancies, costing the economy $2 trillion annually.
Adiponectin has been identified as having pleiotropic functions widely associated with anti - atherogenic, anti - diabetic, cardioprotective and anti - inflammatory effects.
'Lo último en obesidad'. Este es el título del Simposio Internacional que organizamos en la Fundación Ramón Areces los días 1 y 2 de diciembre de 2015. En colaboración con la Fundación General CSIC, reunió a algunos de los mayores expertos en la materia para analizar cómo reducir este grave problema de salud pública.
Intermittent fasting had a strong anti inflammatory effect beside the many other benefits. Intermittent fasting is an eating pattern and Interventional strategy where in individuals are subjected to varying periods of fasting. It doesn’t specify which foods you should eat but rather when you should eat them. Intermittent fasting (IF) is an eating pattern that cycles between periods of fasting and eating. It’s currently very popular in the health and fitness community. Recently attracted attention because:
1- Its Evidence-Based Health Benefits
2- Its potential for correcting metabolic Abnormalities
3- Better adherence than other methods
Emerging evidence indicates that impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin. In contrast to normal cells, which derive most of their usable energy from oxidative phosphorylation, most cancer cells become heavily dependent on substrate level phosphorylation to meet energy demands. Evidence is reviewed supporting a general hypothesis that genomic instability and essentially all hallmarks of cancer, including aerobic glycolysis (Warburg effect), can be linked to impaired mitochondrial function and energy metabolism. A view of cancer as primarily a metabolic disease will impact approaches to cancer management and prevention
A Review on Protein and Cancer ; Etiology, Metabolism and ManagementAbdulrahman Ragab
Altered metabolism is one of the hallmarks of cancer cells. Cell cycling and protein synthesis are both key
physiological tasks for cancer cells. In recent years, interest has been renewed as clear that many of the signaling
pathways that are affected by genetic mutations and the tumor microenvironment have a profound effect on core
metabolism of cancer cells. Metabolic alterations in cancer cells are numerous and include aerobic glycolysis,
reduced oxidative phosphorylation and the increased generation of biosynthetic intermediates needed for cell
growth and proliferation. Furthermore, accelerated protein turnover seen in many cancer patients and whole body
protein turnover is increased with advancing stage of disease. Cancer cells alter their consumption and the way
they process sugars, fats, amino acids and other energy sources to satisfy the demands of continuous proliferation.
The possible effects of specific amino acid, methionine, asparagine, arginine, tyrosine and glutamine, etc. on
protein cancer metabolism are discussed. Evidences confirm a contribution of proteins in all cancer stages and
describe metabolism of protein in cancer and how amino acids can be targeted to management or initially prevent
different types of cancer. Several studies suggest that people who eat more red meat have higher risk for
developing colorectal cancer than those who eat less red meat, but avoiding processed meats is even more
important for cancer prevention. In this review we summarize the role of proteins in cancer etiology, metabolism,
its complication, prevention and treatments.
This PowerPoint presentation shares vital information on leptin and exactly what comprises the foundation for the Venus Factor system. Leptin is a powerful enzyme for weight loss and because of this, proper leptin resistance management has provided great success to women wanting to burn fat.
Recent lecture (june 2011)
Nutrigenomics of FAT: What is “good” or “bad” for human health?
Less healthy: Dietary fats rich in long chain saturated fatty acids that can be pro-inflammatory if chronically “overconsumed”
More favorable: Unsaturated fatty acids (in particular PUFAs from fish oil) have anti-inflammatory properties
A healthy adipose tissue is essential to efficiently store fat and prevent ectopic fat deposition
Healthy : Subcutanous fat > visceral fat > ectopic fat : Unhealthy
Future challenge: To prevent the unhealthy effects of a surplus of added sugars (sucrose, fructose) & high GI carbs
Will be converted into saturated fat
Linked to ectopic fat deposition e.g. NASH
Linked to obesity, diabetes, CVD….
Childhood obesity
My recent introduction talk for the Nutrigenomics Masterclass 2011in Wageningen (The Netherlands):
How to use Nutrigenomics & molecular nutrition? From challenges to solutions
The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...Randox Reagents
Obesity is a major risk factor for type 2 diabetes mellitus (T2DM), insulin resistance (IR), cardiovascular disease (CVD) and various types of malignancies, costing the economy $2 trillion annually.
Adiponectin has been identified as having pleiotropic functions widely associated with anti - atherogenic, anti - diabetic, cardioprotective and anti - inflammatory effects.
'Lo último en obesidad'. Este es el título del Simposio Internacional que organizamos en la Fundación Ramón Areces los días 1 y 2 de diciembre de 2015. En colaboración con la Fundación General CSIC, reunió a algunos de los mayores expertos en la materia para analizar cómo reducir este grave problema de salud pública.
Intermittent fasting had a strong anti inflammatory effect beside the many other benefits. Intermittent fasting is an eating pattern and Interventional strategy where in individuals are subjected to varying periods of fasting. It doesn’t specify which foods you should eat but rather when you should eat them. Intermittent fasting (IF) is an eating pattern that cycles between periods of fasting and eating. It’s currently very popular in the health and fitness community. Recently attracted attention because:
1- Its Evidence-Based Health Benefits
2- Its potential for correcting metabolic Abnormalities
3- Better adherence than other methods
Emerging evidence indicates that impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin. In contrast to normal cells, which derive most of their usable energy from oxidative phosphorylation, most cancer cells become heavily dependent on substrate level phosphorylation to meet energy demands. Evidence is reviewed supporting a general hypothesis that genomic instability and essentially all hallmarks of cancer, including aerobic glycolysis (Warburg effect), can be linked to impaired mitochondrial function and energy metabolism. A view of cancer as primarily a metabolic disease will impact approaches to cancer management and prevention
A Review on Protein and Cancer ; Etiology, Metabolism and ManagementAbdulrahman Ragab
Altered metabolism is one of the hallmarks of cancer cells. Cell cycling and protein synthesis are both key
physiological tasks for cancer cells. In recent years, interest has been renewed as clear that many of the signaling
pathways that are affected by genetic mutations and the tumor microenvironment have a profound effect on core
metabolism of cancer cells. Metabolic alterations in cancer cells are numerous and include aerobic glycolysis,
reduced oxidative phosphorylation and the increased generation of biosynthetic intermediates needed for cell
growth and proliferation. Furthermore, accelerated protein turnover seen in many cancer patients and whole body
protein turnover is increased with advancing stage of disease. Cancer cells alter their consumption and the way
they process sugars, fats, amino acids and other energy sources to satisfy the demands of continuous proliferation.
The possible effects of specific amino acid, methionine, asparagine, arginine, tyrosine and glutamine, etc. on
protein cancer metabolism are discussed. Evidences confirm a contribution of proteins in all cancer stages and
describe metabolism of protein in cancer and how amino acids can be targeted to management or initially prevent
different types of cancer. Several studies suggest that people who eat more red meat have higher risk for
developing colorectal cancer than those who eat less red meat, but avoiding processed meats is even more
important for cancer prevention. In this review we summarize the role of proteins in cancer etiology, metabolism,
its complication, prevention and treatments.
This PowerPoint presentation shares vital information on leptin and exactly what comprises the foundation for the Venus Factor system. Leptin is a powerful enzyme for weight loss and because of this, proper leptin resistance management has provided great success to women wanting to burn fat.
Recent lecture (june 2011)
Nutrigenomics of FAT: What is “good” or “bad” for human health?
Less healthy: Dietary fats rich in long chain saturated fatty acids that can be pro-inflammatory if chronically “overconsumed”
More favorable: Unsaturated fatty acids (in particular PUFAs from fish oil) have anti-inflammatory properties
A healthy adipose tissue is essential to efficiently store fat and prevent ectopic fat deposition
Healthy : Subcutanous fat > visceral fat > ectopic fat : Unhealthy
Future challenge: To prevent the unhealthy effects of a surplus of added sugars (sucrose, fructose) & high GI carbs
Will be converted into saturated fat
Linked to ectopic fat deposition e.g. NASH
Linked to obesity, diabetes, CVD….
Childhood obesity
My recent introduction talk for the Nutrigenomics Masterclass 2011in Wageningen (The Netherlands):
How to use Nutrigenomics & molecular nutrition? From challenges to solutions
We are what we eat - The role of diets in the gut-microbiota-health interactionNorwich Research Park
Lecture at Summer School Nutrigenomics in Camerino Italy Sept. 2016.
The (small) intestine has increasingly been recognized to play a key role in the early phase of pro-inflammatory disturbances e.g. by enhanced overflow of dietary components to the distal intestine (ileum, colon) and affecting the gut microbiota & their metabolites (e.g. bile acids, short chain fatty acids). Transcription factors e.g. PPARγ, FXR, AHR or NRF2 are involved in host sensing mechanisms of microbial metabolites. Strong impact of dietary composition on small and large intestinal microbiota and their metabolic functions.
Targeting the (small) intestine and its microbiota with (plant) foods, bioactives, probiotics and drugs will improve gut and liver functions with strong implications for human health during life.
You can not change your genome but can influence how it is used by healthy food patterns and lifestyle. This talk focuses on the gut as a primary gatekeeper between foods, the microbiota and the immuno-metabolic system of the host. The underlying biology is complex but well regulated if the system is not chronically overloaded.
What is health? NUGO International nutrigenomics Conference Wageningen Sept 9...Norwich Research Park
What is health? Can Nutrigenomics allow to quantify metabolic health? (YES)
My very personal conclusions of a wonderful conference (NUGO Week 2011) in Wageningen (The Netherlands) that we organized.
П. Сутерс "Проявления инсулинорезистентности и гликемический контроль в интен...rnw-aspen
Доклад с 15 Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 мая 2015 г
How I used Twitter the last 3 years to discuss the impact of healthy nutrition & lifestyle for personal health => field of Nutrigenomics (you are what you eat and have eaten).
Short intro epigenetics & nutrigenomics& the early impact of nutrition Norwich Research Park
Our “genes” are not fixed: “Plasticity” of the genotype by epigenetic mechanisms => important for the phenotypic impact of nutrition.
• Histone and DNA modifications have impact on gene transcription efficiency. Methylation (more stable) and acetylation (more flexible) have impact on chromatin
structures.
• Epigenetic modifications have impact on offspring, embryo development, ageing and disease development or prevention => example: Dutch Hunger Winter.
Health status of future parents are very important for the future health of children.
Early healthy nutrition & lifestyle essential for successful healthy life & “ageing”.
This presentation from the recent international nutrition conference in Bangkok presents a short overview about several aspects of state-of-the art nutrigenomics & molecular nutrition research.
Conclusion
Nutrigenomics enables us
-To understand how nutrition precisely works (evidence-based nutrition);
-To quantify the nutritional needs for optimized fitness at different life stages (“personalized” nutrition);
-To improve early diagnostics of nutrition related disorders (“challenge tests”);
-To support the development of “smart foods” for modern mankind (healthy and tasty, sustainable, affordable)
-To enable the transition of nutritional science to nutritional science 2.0
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Adipose tissue innate immunity & inflammation - a nutrigenomics perspective of the metabolic syndrome
1. Adipose tissue, innate immunity and inflammation – a nutrigenomics perspective of the metabolic syndrome http://twitter.com/nutrigenomics Michael MüllerNetherlands Nutrigenomics Centre & Nutrition, Metabolism and Genomics GroupDivision of Human Nutrition, Wageningen University
2. I will talk about Our challenges: What is healthy What is Nutrigenomics? The metabolic syndrome The deadly sins Good fat / bad fat (tissue) Modern nutritional science & early biomarkers NASH & the role of the adipose tissue Dietary saturated fat can induce pro-inflammatory responses We have different phenotypes: Personalized health Saturated fat can be “killing” (in transgenic mice) Summary & recommendations
6. Our “paleolithic” genes + modern diets Paleolithic era Modern Times 1.200.000 Generations between feast en famine 2-3 Generations in energy abundance % Energy % Energy 100 100 Grain Milk/-products Isolated Carbohydrates Isolated Fat/OilAlcohol Low-fat meatChicken Eggs Fish 50 Meat Chicken Fish 50 Fruit Vegetables (carrots) Nuts Honey Fruit Vegetables Beans 0 0
9. What is the metabolic syndrome? The metabolic syndrome is characterized by a group of metabolic risk factors in one person: Central obesity (excessive fat tissue in and around the abdomen) Atherogenic dyslipidemia (blood fat disorders — mainly high triglycerides and low HDL cholesterol — that foster plaque buildups in artery walls) Raised blood pressure (130/85 mm Hg or higher) Insulin resistance or glucose intolerance (the body can’t properly use insulin or blood sugar) Prothrombotic state (e.g., high fibrinogen or plasminogen activator inhibitor in the blood) Proinflammatory state (e.g., elevated high-sensitivity C-reactive protein in the blood)
13. Normal Type 2 Diabetes Visceral Fat Distribution:Normal vs Type 2 Diabetes
14.
15. We need a new nutritional science Insulin ± oral agents Oral combination Oral monotherapy Diet & exercise Complex Disease 100 Different & similar targets 80 Pharma 60 DISEASE STATE (%) 40 Nutrition 20 0 TIME (months/years) HomeostasisHealth L. Afman & M. Müller J Am DietAssoc. 2006;106:569-576.
16. Late biomarkersof disease Earlybiomarkersof disease Onset of disease Biomarkers of earlydiseasestate Single marker vsmultimarker profiles Disease Pharma Nutrition Early biomarkers in human nutrition research healthy
17. Organ-specific gene expression signatures of the early phase (metabolic stress) & the late phase of metabolic syndrome 1 2 3 4 10 16 Weeks WAT 1 2 3 4 10 16 Weeks Muscle 1 2 3 4 10 16 Weeks Liver 1 2 3 4 10 16 Weeks Intestine Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy
25. Role of macrophages in lipid metabolism (JBC 2008; Cell Metabolism 2010)hepatic steatosis steatohepatitis (NASH) & fibrosiscirrhosis
26. Study: Interaction between WAT and liver tissue essential for NASH/NAFLD in C57Bl/6 mice Objective: Nonalcoholic fatty liver disease (NAFLD) is strongly linked to obesity and diabetes, suggesting an important role of adipose tissue in the pathogenesis of NAFLD. Here we aimed to investigate the interaction between adipose tissue and liver in NAFLD, and identify potential early plasma markers that predict NASH.
36. Plasma proteins as early predictive biomarker for NASH in C57Bl/6 mice Multivariate analysis of association of protein plasma concentrations with final liver triglyceride content
37. Conclusions Our data support the existence of a tight relationship between adipose tissue dysfunction and NASH pathogenesis. It points to several novel potential predictive biomarkers for NASH. Duval C, Thissen U, Keshtkar S, Accart B, Stienstra R, Boekschoten MV, Roskams T, Kersten S, Müller M. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes. 2010;59:3181-91.
38.
39. Human nutrigenomics study Dietary fat and inflammation in adipose tissue Change in diet composition ? Van Dijk et al. AJCN 2009 de Luca, C and Olefsky JM, Nature Medicine 12, 41 - 42 (2006)
45. ‘Obese-linked’ pro-inflammatory gene expression profile by SFAs MUFA diet SFA diet The SFA-rich diet: Induces a pro-inflammatory obese-linked gene expression profile Decreases expression and plasma level of the anti-inflammatory cytokine adiponectin “Personal Transcriptomes” Van Dijk et al. AJCN 2009
46. Humanstudy:Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects AIM Associate plasma protein profiles with BMI Identifypotential marker profile of earlydisease state . PLoS One. 2010 Dec 23;5(12):e14422
47. Measurements RulesBasedMedicine (Austin, USA) Multiplex immunoassay In total 124 proteinsmeasured Involved in diseases, inflammation, endothelialfunction and metabolism . PLoS One. 2010 Dec 23;5(12):e14422
48. We are different: improved phenotyping necessary to reveal phenotype clusters . PLoS One. 2010 Dec 23;5(12):e14422
49. Conclusion We identified clusters of plasma proteins associated with BMI and insulin in a healthy population. These clusters included earlier identified biomarkers for obesity-related disease as well as potential new biomarkers. These plasma protein clusters could have potential applications for improved phenotypic characterization of volunteers in nutritional intervention studies or as biomarkers in the early detection in obesity-linked disease development and progression. van DijkSJ, Feskens EJM, Heidema AG, Bos MB, van de Rest O, Geleijnse JM, de Groot CPGM, Müller M, Afman LA. Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects. PLoS One. 2010 Dec 23;5(12):e14422
57. MLN-resident macrophages are protected from the pro-inflammatory effect of saturated fatty acids via expression of Angptl4, which is strongly induced by chyle and fatty acids and which via inhibition of LPL prevents lipolysis of chylomicron-TG.
58. In the absence of this protective mechanism, feeding a diet rich in saturated fat rapidly leads to enhanced lipid uptake into MLN-resident macrophages, triggering foam cell formation and a massive inflammatory response.Lichtenstein et al. Cell Metab. 2010
60. Pharma is not the (only) solution:Eat foods rich in challenging food bioactives Drugs A B C PPARg PPARb PPARa Receptor C3 C2 C1 Fatty acids F C6 C5 C4 Multiple targets
61. Summary You are what you eat => during life all events will leave their (epigenetic) traces on our genome, some are irreversible => ageing Disease phenotypes such as obesity, metabolic syndrome, diabetes are largely related to our “gluttony / sloth” lifestyles and modern convenient (“fast”) foods => unhealthy ageing. NASH is the liver phenotype of the metabolic syndrome and appears early in the progression towards diabetes or CVD. There is a tight relationship between adipose tissue dysfunction and NASH pathogenesis. Chronic overconsumption of saturated fat or lipogenic precursors (starch, sugars) induces non-resolving low-grade pro-inflammatory state largely caused by the innate immune system. => choose the right lifestyle & food pattern (diverse & anti-inflammatory), eat less & exercise more (at least for 30 minutes/day).
62. 2 Meals a day, work as long as possible & embrace challenge Walter Breuning (1896 - 2011)
63. Sander KerstenLinda SandersonNatasha Georgiadi Mark BouwensLydia Afman Guido Hooiveld Meike Bunger Philip de Groot Mark Boekschoten Nicole de Wit Mohammad Ohid Ullah Christian Trautwein Folkert Kuipers Ben van Ommen + many more
Editor's Notes
Inflammation has been associated with many disease phenotypes including steatohepatitis or diabetes. This relationship is in particular when inflammation is chronic or non-resolving. There is an interaction between metabolism and inflammation with positive or negative consequences with respect to organ and systemic health.In my talk I will briefly discuss two unpublished studies, one investigating the important interaction of WAT and liver in particular under conditions of diet-induced obesity. Organ-specific macrophages in WAT and liver play an crucial role in progressing organ-specific inflammatory phenotypes. In the second study we found very interesting interaction between dietary fat and macrophages in mesenteric lymph nodes that are exposed postprandially to very high concentrations of chylomicrons. We used a k.o. mouse for ANGPTL4 and could show that chronic consumption of saturated fat can be deadly.
Haematoxylin and eosin staining (D) and oil red O staining (E) of representative liver sections of the 4 subgroups
(Immuno)histochemical staining confirms enhanced inflammation and early fibrosis in HFH miceImmunohistochemical staining of macrophage activation in representative liver section of HFL and HFH mice using antibody against the specific macrophagemarker Cd68Collagen staining using fast green FCF/sirius red F3B. Staining of stellate cell activation using antibody against GFAP.
- Number of genes up- or down-regulated in the various subgroups in comparison to the LFL mice, as determined by Affymetrix GeneChip analysis. Genes with a p-value below 0.05 were considered significantly regulated. - Heat map showing changes in expression of selected genes involved in lipid metabolism, inflammation and fibrosis in liver. Changes in gene expression of selected genes as determined by real-time quantitative PCR. Mean expression in LFL mice was set at 100%. Error bars reflect standard deviation. Bars with different letters are statistically different (P<0.05 according to Student’s t-test). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
Haematoxylin and eosin staining of representative adipose tissue sections. Immunohistochemical staining of macrophages using antibody against Cd68. Collagen staining using fast green FCF/sirius red F3B.
Adipose tissue mRNA expression of a selected group of genes was determined by quantitative real-time PCR after 21 weeks of dietary intervention. Mean expression in LFL mice was set at 100%. Error bars reflect standard deviation. * = significantly different from HFL mice according to Student’s t-test (P<0.05). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
. A) Plasma concentration of haptoglobin, TIMP-1, IL-1β, leptin and insulin were determined by multiplex assay at specific time points during the 21 weeks of dietary intervention after a 6h fast. White squares: LFL, Light grey squares: LFH, dark grey squares: HFL, black squares: HFH. Error bars reflect standard deviation. * = significantly different from HFL mice according to Student’s t-test (P<0.05). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
Graphs illustrating the result of multivariate analysis showing the association of protein plasma concentrations at various time points with final liver triglyceride content. Significant proteins display an inverse RSD value higher than 2 (bold line indicates the inverse RSD threshold value of 2).RSD = Relative standard deviation.